L530-0137 Screening compound: 4-{4'-fluoro-[1,1'-biphenyl]-4-sulfonamido}-N-phenylbenzamide

L530-0137 Screening compound: 4-{4'-fluoro-[1,1'-biphenyl]-4-sulfonamido}-N-phenylbenzamide
L530-0137 Screening compound: 4-{4'-fluoro-[1,1'-biphenyl]-4-sulfonamido}-N-phenylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L530-0137
4-{4'-fluoro-[1,1'-biphenyl]-4-sulfonamido}-N-phenylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L530-0137

Molecular Formula

C25H19FN2O3S (C25 H19 FN2 O3 S)

Compound Name

4-{4'-fluoro-[1,1'-biphenyl]-4-sulfonamido}-N-phenylbenzamide

IUPAC name

4-{4'-fluoro-[11'-biphenyl]-4-sulfonamido}-N-phenylbenzamide

SMILES

O=C(c(cc1)ccc1NS(c(cc1)ccc1-c(cc1)ccc1F)(=O)=O)Nc1ccccc1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.5

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.458

Distribution Coefficient, logD

4.608

Water Solubility, LogSw

-6.08

Polar Surface Area

63.708

Acid Dissociation Constant (pKa)

6.62

Base Dissociation Constant (pKb)

-1.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

L530-0137 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Autophagy-Targeted Library (4564 compounds)

Integrin Receptors Targeted library (1715 compounds)

Nucleic Acid Ligands (8311 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
Targets:
  • Others

References: we are preparing a list of scientific research reports with L530-0137 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L530-0137?
Check Price and Availability of L530-0137, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L530-0137 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L530-0137
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L530-0137
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L530-0137 available by request